Education: Graduate of the Business Professionals Course (BPC), 1997. The Aji Network, Ph.D. Biochemistry, 1982. University of Illinois, Urbana, Illinois M.Sc. Biochemistry, 1977. University of Calgary, Alberta, Canada B.Sc. Microbiology (Honors), 1975. University of Calgary, Alberta, Canada
Languages: English and some Afrikaans
REFEREED JOURNAL ARTICLES: 1) Vermylen, V., J-E Fortier, E. Rulier, A. Bernard, C. Jone, and J.O. Neway. 2017. Finding Relationships Between Clinical Batch Quality Data and Patient Outcomes. Pharm. Eng. September-October: 60-66 2) Shashilov, V and J.O. Neway. 2012. Traditional Lot Traceability Approaches are Not Sufficient to Enable Upstream/Downstream Correlation Analysis for QbD. Pharmaceutical Engineering. 32(5): 52-62 3) Blackmore, R.S., J.S. Blome, and J.O. Neway. 1996. A complete computer monitoring and control system using commercially availaibe, configurable software for laboratory and pilot plant Escherichia coli fermentations. J. Ind. Microbiol. 16:383-389. 4) Looker, D., A.J. Mathews, J.O. Neway, and G.L. Stetler. 1994. Expression of Recombinant Human Hemoglobin in Escherichis coli. Meth. Enzymol. 231:364-374. 5) Bauer, K.A., A. Ben Bassat, M. Dawson, V.T. de la Puente, and J.O. Neway. 1990. Improved expression of human Interleukin 2 in high-cell-density fermentor cultures of Escherichia coli K 12 by a phosphotransacetylase mutant. Appl. Environ. Microbiol. 56:1296-1302. 6) MacDonald, H.L., and J.O. Neway. 1990. Effects of medium quality on the expression of human Interleukin 2 at high cell density in fermentor cultures of Escherichia coli. Appl. Environ. Microbiol. 56:640-645. 7) Lam, K.S., J.O. Neway, and G.M. Gaucher. 1988. In vitro stabilization of 6 methylsalicylic acid synthetase from Penicillium urticae. Can. J. Microbiol. 34:30 37. 8) Neway, J.O., and R.L. Switzer. 1983. Degradation of ornithine transcarbamylase in sporulating Bacillus subtilis cells. J. Bacteriol. 155:522 530. 9) Neway, J.O., and R.L. Switzer. 1983. Purification, characterization, and physiological function of Bacillus subtilis ornithine transcarbamylase. J. Bacteriol. 155:512 521. 10) Gaucher, G.M., K.S. Lam, J.W.D. GrootWassink, J.O. Neway, and Y.M. Deo. 1981. The initiation and longevity of patulin biosynthesis. Dev. Ind. Microbiol. 22:219 232. 11) Neway, J.O., and G.M. Gaucher. 1981. Intrinsic limitations on the continued production of the antibiotic patulin by Penicillium urticae. Can. J. Microbiol. 27:206 215. BOOKS: 1) Neway, J.O., (Ed). 1989. Fermentation Process Development of Industrial Organisms. 324 pages. Marcel Dekker Inc. New York. Six Chapters: Actinomycetes by J. P. DeWitt, J. V. Jackson and T. J. Paulus (Abbott Labs, USA), Fermentation of Bacilli by F. G. Priest (Heriot-Watt University, Edinburgh) and R. J. Sharp (Center for Applied Microbiology and Research, Porton Down), Coryneform Bacteria by I. Shiio and S. Nakamori (Ajinomoto Co., Japan), Bioprocess Technology in Industrial Fungi by R. P. Elander (Bristol-Myers Co., USA), Using Mammalian Cells to Produce Products by C. L. Propst (Affiliated Scientific, USA), R. J. von Wedel (Cytoculture International, USA) and A. S. Lubiniecki (Genentech, USA), and Growth of Yeasts by D. R. Berry (University of Strathclyde, Scotland). ISSUED PATENTS: 1) Ruth, J. D., Dorr, S. A., Junak, J. A., Libouban, O., and Neway, J. O. System, Method and Computer Program for Mapping a Hierarchical Display of Process Data of Multi-database Origins. 354018[6,741,998]. 5-25-2004. USA. 1-30-2001. 2) Ruth, J. D., Dorr, S. A., Galemmo, N., Junak, J. A., Libouban, O., and Neway, J. O. System, Method and Computer Program for Assembling Process Data of Multi-database Origins Using a Hierarchical Display. 816547[6,725,230]. 4-20-2004. USA. 3-26-2001. 3) Neway, J. O., Durfee, S. L., and Jahn, G. L. System for Analyzing and Improving Pharmaceutical and Other Capital-intensive Manufacturing Processes. 392928[6,243,615]. 6-5-2001. USA. 9-9-1999. 4) Plomer, J. J., Ryland, J. R., Matthews, M-A. H., Traylor, D. W., Milne, E. E., Durfee, S. L., Mathews, A. J., and Neway, J. O. Purification of Hemoglobin. 438511[5,840,851]. 1998. USA. 5-10-1995.
LinkedIN Profile: https://www.linkedin.com/in/justinneway/
Experience Description: Applied Materials, Santa Clara, California - 11/17 to present - Senior Fellow, Technical Advisory Board Dassault Systèmes BIOVIA, Broomfield, Colorado – 10/12 to 2/17 - BIOVIA Vice President and Managing Director, Process Production Operations - Senior Fellow, BIOVIA Science Council Aegis Analytical Corporation, Lafayette, Colorado - 2/97 to 10/12 - Founder, Vice President, Chief Science Officer and Corporate Secretary Baxter Biosciences (aka Somatogen), Boulder, Colorado - 7/90 to 3/97 - Director, Fermentation R&D (11/94 to 2/97) - Director, Process Sciences (4/92 to 11/94) - Director, Process Development (4/91 to 4/92) - Director, Fermentation (7/90 to 4/91) Novartis Vaccines (aka Cetus), Emeryville, California - 11/86 to 7/90 - Director, Fermentation R&D Pfizer BioTherapeutics (aka Genetics Institute), Cambridge, Massachusetts - 12/82 to 11/86 - Principal Scientist, Fermentation Development UNIVERSITY OF ILLINOIS, Urbana, Illinois - 5/79 to 12/82 - Research Biochemist UNIVERSITY OF WESTERN ONTARIO, Ontario, Canada - 9/78 to 5/79 - Senior Demonstrator, Chemistry Department
Meet in Person
If you’re looking for uncommon success in your career as a technical executive, manager or entrepreneur, Justin can help you navigate more effectively based on his many years of experience leading and managing multi-disciplinary teams in pharmaceuticals and biotechnology. You will benefit from his proven abilities as a scientist, entrepreneur and founder of a successful technical software company for which he provided leadership, creativity, innovation, and venture funding for his team developing, testing, marketing, selling and supporting technical software systems. Justin also draws from his first-hand experience of the human and technical sides of the change management needed when a small company is acquired and integrated into a much larger corporation. He knows how to translate complex technical concepts into understandable language, how to make effective presentations to a wide range of large and small technical and non-technical audiences, and how to work effectively with industry analysts and the media.